Japanese authors investigated the mechanism of reduced efficacy of emicizumab in an adult patient with hemophilia A and an inhibitor, whose treatment was discontinued due to repeated bleeding episodes with prolonged aPTT.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
